USA – New Study: Abortion Pill Injures more Women than FDA Reports
A team of over 30 board certified physicians spent three years reviewing thousands of pages of adverse events reports submitted to the U.S. Food and Drug Administration (FDA) by abortion pill manufacturer Danco. The study was published in Issues in Law & Medicine in January this year. The study found large amounts of underreported complications. Factors that contributed to the underreporting were that 60% of surgical abortions, due to abortion pill complications, were not handled by the abortion facility, and less than half of the women who suffered complications went to the emergency room instead of getting treatment at the abortion facility. The most common complications included a failed abortion, an incomplete abortion, infection and a missed ectopic pregnancy.
“Some of the patient deaths were not known to the abortion provider until they saw the death in an obituary or were contacted by an outside source,” the researchers wrote and propose that abortion providers, hospitals, emergency departments, and private practitioners should be required to report on abortion complications. Moreover, the FDA should strengthen reporting systems because in 2016, under the Obama administration, the FDA stopped requiring Danco to report non-fatal abortion complications to the government, and the reports that were submitted lacked detail and many patients were lost to follow-up.
England de-regulated the abortion drug during the pandemic last year and saw disastrous consequences. There have been numerous reports of health and safety problems, including two women who died after taking the drugs. In another case, authorities are investigating how a woman who was 28-weeks pregnant received the abortion drugs in the mail and used them to abort her viable, late-term unborn baby. In the United States, mifepristone has been linked to at least 24 women’s deaths and 4,000 serious complications.
Because of the risk associated with taking mifepristone, coupled with misoprostol to abort unborn babies, the FDA requires abortion facilities to administer the drug in-person after an examination. Now, abortion activists are demanding that the Biden administration get rid of safety requirements for the abortion drug and allow the drug to be distributed by telemedicine, meaning the mother may never see a doctor or have an ultrasound before she takes the drug and aborts her unborn baby. Now that Marie Stopes is delivering abortion pills to South African (SA) women via Telemedicine, SA can expect similar sad results.